Solid Biosciences is a life science company based in Charlestown, MA that is dedicated to advancing genetic medicines for neuromuscular and cardiac diseases. Founded by individuals affected by Duchenne muscular dystrophy, Solid Biosciences is driven by a mission to accelerate the discovery and development of treatments that can benefit all patients with Duchenne. They are committed to expanding their efforts to include other neuromuscular and cardiac diseases to provide meaningful treatments to a wider patient population.

Solid Biosciences offers a robust pipeline of programs and innovative scientific publications and presentations to further their understanding and measurement of genetic medicines. They have a strong infrastructure in place for manufacturing and are dedicated to providing an array of resources and support for patients and caregivers, including educational materials, patient stories, and engagement with the community. By joining forces with collaborative partners and experts in the field, Solid Biosciences is continuously working towards their vision of transforming the lives of patients affected by genetic diseases.

Stay connected with Solid Biosciences on LinkedIn and Twitter to stay informed about their latest endeavors